363sek
-6,0 %
Date:2025-05-14Time:17:29:37Latest report:Q4-2024List:NGMTicker:COEGIN
Market Cap:90 msekEnterprise Value:71 msekNet Sales:- msekEarnings:-23,8 msekEmployees:0ISIN:SE0020357754

Ratios

10-year key figure history for Coegin Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Coegin Pharma with index and moving average MA50 and MA200.

Stockprice:3,63
MA50:4,30
MA200:4,64
Price/MA200:-21,7 %
RSI (14):34,1
Price/MA50:-15,6 %

Description

Coegin Pharma is a Swedish biotechnology company with dermacosmetic projects for hair growth and skin pigmentation, as well as drug candidates for the treatment of heart attacks and leukemia. What the projects have in common is that they are based on patented technology platforms and collaborations with researchers and academics internationally. Coegin Pharma has its headquarters in Lund.

Biotechnology